Article

Calenduloside E Ameliorates Myocardial Ischemia-Reperfusion Injury through Regulation of…

Oxidative Medicine and Cellular Longevity · 2020 · Min Wang, author Rui-ying Wang, author Jia-hui Zhou, author Xue-heng Xie, author Gui-bo Sun, author Xiao-bo Sun, author Ana Lloret, Academic Editor

Key facts

Title Calenduloside E Ameliorates Myocardial Ischemia-Reperfusion Injury through Regulation of AMPK and Mitochondrial OPA1
First author Min Wang, author Rui-ying Wang, author Jia-hui Zhou, author Xue-heng Xie, author Gui-bo Sun, author Xiao-bo Sun, author Ana Lloret, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Jul 7, 2020
DOI 10.1155/2020/2415269
Devices mentioned DEN000008, K022086, K103302, K973350, K990827
Product codes mentioned JCI, KIT, NDS, NJT, OOI, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature